Cobb Stuart
SEC insider (Form 3/4/5 filer). CIK 0001994301. Chief Scientific Officer at Neurogene Inc. (NGNE). 6 reported Form 4/5 transactions since Sep 2024; latest on Mar 13, 2026. Located in NEW YORK, NY.
Companies Cobb Stuart has filed insider reports for
- Neurogene Inc. (NGNE): Officer, Chief Scientific Officer
Cobb Stuart
CIK: 0001994301
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)4 (66.7%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (33.3%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NGNE
Neurogene Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Mar 13, 2026NGNE
Neurogene Inc.
SaleDirect4K shares at avg. $20.41$81K - Mar 13, 2026NGNE
Neurogene Inc.
SaleDirect2.7K shares at avg. $21.34$57K - Mar 13, 2026NGNE
Neurogene Inc.
SaleDirect148 shares at avg. $22.08$3K - Feb 20, 2026NGNE
Neurogene Inc.
AwardDirect16.5K shares- - May 14, 2025NGNE
Neurogene Inc.
SaleDirect6.8K shares at avg. $15.15$103K - Mar 26, 2025NGNE
Neurogene Inc.
AwardDirect7.2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 13, 2026 | NGNE Neurogene Inc. | Sale | 3,991 | $20.41 | $81,456 | Direct |
| Mar 13, 2026 | NGNE Neurogene Inc. | Sale | 2,658 | $21.34 | $56,722 | Direct |
| Mar 13, 2026 | NGNE Neurogene Inc. | Sale | 148 | $22.08 | $3,268 | Direct |
| Feb 20, 2026 | NGNE Neurogene Inc. | Award | 16,500 | - | $0 | Direct |
| May 14, 2025 | NGNE Neurogene Inc. | Sale | 6,797 | $15.15 | $103,003 | Direct |
| Mar 26, 2025 | NGNE Neurogene Inc. | Award | 7,200 | - | - | Direct |
1-6 of 6 transactions